Literature DB >> 2450175

Marked depletion of dorsal spinal cord substance P and calcitonin gene-related peptide with intact skin flare responses in multiple system atrophy.

P Anand1, R Bannister, G P McGregor, M A Ghatei, P K Mulderry, S R Bloom.   

Abstract

In view of the presence of neuropeptides in spinal cord autonomic pathways, their regional concentration was studied in post mortem thoracic cord from four cases of multiple system atrophy with progressive autonomic failure (MSA). A marked depletion was observed of substance P, its related peptide substance K, and of calcitonin gene-related peptide (CGRP), particularly in dorsal regions where peptide-containing sensory fibres terminate. As substance P and CGRP in primary sensory fibres are considered mediators of skin flares in Lewis' triple response, histamine-induced skin flares were measured in 12 MSA patients and were found to be preserved. These results provide a new key to the classification and aetiology of autonomic and multiple system degenerations, as well as a model to study the role of sensory neuropeptides in man.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2450175      PMCID: PMC1031529          DOI: 10.1136/jnnp.51.2.192

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  10 in total

Review 1.  Autonomic neuroeffector junctions--reflex vasodilatation of the skin.

Authors:  G Burnstock
Journal:  J Invest Dermatol       Date:  1977-07       Impact factor: 8.551

2.  Topical capsaicin pretreatment inhibits axon reflex vasodilatation caused by somatostatin and vasoactive intestinal polypeptide in human skin.

Authors:  P Anand; S R Bloom; G P McGregor
Journal:  Br J Pharmacol       Date:  1983-04       Impact factor: 8.739

Review 3.  If substance P fails to fulfil the criteria as a neurotransmitter in somatosensory afferents, what might be its function?

Authors:  P D Wall; M Fitzgerald
Journal:  Ciba Found Symp       Date:  1982

4.  Depletion of substance P-containing axons in substantia gelatinosa of patients with diminished pain sensitivity.

Authors:  J Pearson; L Brandeis; A C Cuello
Journal:  Nature       Date:  1982-01-07       Impact factor: 49.962

5.  Substance P and enkephalins in spinal cord after limb amputation.

Authors:  S P Hunt; M N Rossor; P C Emson; V Clement-Jones
Journal:  Lancet       Date:  1982-05-01       Impact factor: 79.321

Review 6.  Neurochemical pathology of brain peptides.

Authors:  J A Edwardson; J R McDermott
Journal:  Br Med Bull       Date:  1982-09       Impact factor: 4.291

7.  Unmyelinated axons in the posterior funiculi.

Authors:  L A Langford; R E Coggeshall
Journal:  Science       Date:  1981-01-09       Impact factor: 47.728

8.  Vasopressin, oxytocin and neurophysins in the human brain and spinal cord.

Authors:  J S Jenkins; V T Ang; J Hawthorn; M N Rossor; L L Iversen
Journal:  Brain Res       Date:  1984-01-16       Impact factor: 3.252

9.  A VIP-containing system concentrated in the lumbosacral region of human spinal cord.

Authors:  P Anand; S J Gibson; G P McGregor; M A Blank; M A Ghatei; A J Bacarese-Hamilton; J M Polak; S R Bloom
Journal:  Nature       Date:  1983 Sep 8-14       Impact factor: 49.962

10.  Calcitonin gene-related peptide immunoreactivity in the spinal cord of man and of eight other species.

Authors:  S J Gibson; J M Polak; S R Bloom; I M Sabate; P M Mulderry; M A Ghatei; G P McGregor; J F Morrison; J S Kelly; R M Evans
Journal:  J Neurosci       Date:  1984-12       Impact factor: 6.167

  10 in total
  2 in total

1.  Impairment of calcitonin gene-related peptide-induced potentiation of cholinergic sweat secretion in patients with multiple system atrophy.

Authors:  K Kumazawa; G Sobue; T Mitsuma; J Sugenoya; T Ogawa
Journal:  Clin Auton Res       Date:  1997-04       Impact factor: 4.435

2.  Immunohistochemical quantification of substance P in spinal dorsal horns of patients with multiple system atrophy.

Authors:  N Tomokane; T Kitamoto; J Tateishi; Y Sato
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-06       Impact factor: 10.154

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.